Vera Therapeutics Cash Flow Statement (2020-2026) | VERA

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-5.85M-7.25M-16.60M-17.65M-23.44M-33.32M-33.19M-30.51M-21.01M-25.26M-39.05M-33.50M-44.16M-52.99M-50.07M-61.94M-92.52M-81.42M-94.12M-288.25M
Share-based Compensation (Quarter)
0.71M0.93M0.96M1.66M2.02M2.45M-4.14M2.67M2.68M2.92M3.22M4.12M4.87M5.59M6.22M7.74M9.47M9.74M10.96M13.21M
Gains from Investment Securities (Quarter)
0.01M0.14M0.13M
Cash from Operations (Quarter)
-7.67M-5.48M-6.44M-8.98M-19.03M-18.42M-21.16M-26.29M-17.77M-22.97M-25.14M-33.83M-24.78M-36.88M-39.18M-54.41M-54.80M-61.91M-69.99M-106.50M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.56M0.55M0.56M0.59M0.58M0.56M0.55M0.53M0.52M0.50M0.50M0.55M0.46M0.44M0.43M0.11M0.12M
Depreciation & Amortization (CF) (Quarter)
0.01M0.00M0.01M0.01M0.02M0.06M0.09M0.12M0.13M0.14M0.14M
Change in Working Capital
Change in Account Payables (Quarter)
1.01M-0.76M0.42M5.94M-0.24M-0.07M4.98M-6.67M7.95M-0.98M-1.18M-5.91M-0.55M-0.06M3.06M1.60M3.90M4.79M3.62M-7.97M
Change in Accured Expenses (Quarter)
0.08M1.02M3.22M4.22M-2.41M0.47M4.75M4.64M-4.61M-1.19M-1.05M-1.69M4.58M8.07M-3.77M-4.78M8.10M3.92M7.21M-0.44M
Other Working Capital Changes (Quarter)
-0.63M-0.64M-0.65M-0.69M-0.68M-0.67M-0.65M-0.65M-0.64M-0.62M-0.62M-0.53M-0.39M-0.47M-0.52M-0.10M-0.18M
Investing Activities
Capital Expenditures (Quarter)
0.02M0.01M0.04M0.06M0.09M0.24M0.65M0.19M0.21M0.13M0.10M0.02M
Change in Acquisitions & Divestments (Quarter)
16.00M38.00M24.00M36.90M22.40M44.90M71.82M31.68M58.50M111.50M73.28M106.25M126.06M168.59M105.27M87.92M
Cash from Investing Activities (Quarter)
0.80M-5.00M-39.45M-42.09M-2.44M13.44M12.23M-86.45M16.23M18.56M-219.29M-22.68M38.32M-221.38M15.32M28.54M69.76M80.66M-137.82M
Financing Activities
Other financing activities (Quarter)
50.83M-50.63M0.23M0.05M0.97M0.83M0.24M0.43M0.30M0.09M6.91M3.44M0.75M2.31M1.53M0.46M0.80M4.19M3.94M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
2.89M1.40M3.49M3.80M1.10M3.82M0.50M0.26M0.34M2.61M0.43M0.68M6.61M2.54M0.69M1.44M8.40M4.07M
Net Equity Issued and Repurchased (Quarter)
51.18M-51.18M86.13M
Misc.
Cash from Financing Activities (Quarter)
48.99M4.92M80.27M0.05M0.91M20.71M107.98M0.43M0.30M24.83M276.54M3.44M0.74M325.95M1.53M20.29M0.80M286.28M3.94M
Change in Cash (Quarter)
42.12M-5.48M-6.52M31.83M-61.08M-19.95M12.98M93.93M-103.79M-6.45M18.24M23.42M-44.02M2.17M65.39M-37.56M-5.97M8.65M296.95M-240.37M
Free Cash Flow (Quarter)
-7.67M-5.48M-6.44M-9.00M-19.04M-18.46M-21.16M-26.29M-17.77M-22.97M-25.21M-33.83M-24.87M-37.12M-39.83M-54.59M-55.01M-62.04M-70.10M-106.52M
Net Cash Flow (Quarter)
42.12M-5.48M-6.52M31.83M-61.08M-19.95M12.98M93.93M-103.79M-6.45M18.24M23.42M-44.02M2.17M65.39M-37.56M-5.97M8.65M296.95M-240.37M